Cargando…
Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a chronic complex systemic autoimmune disease characterized by multiple autoantibodies and clinical manifestations, with the potential to affect nearly every organ. SLE treatments, including corticosteroids and immunosuppressive drugs, have greatly increased sur...
Autores principales: | Robinson, Sean, Thomas, Ranjeny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322693/ https://www.ncbi.nlm.nih.gov/pubmed/34335564 http://dx.doi.org/10.3389/fimmu.2021.654701 |
Ejemplares similares
-
Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves’ disease
por: Zala, Aakansha, et al.
Publicado: (2022) -
Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes
por: Thomas, Ranjeny, et al.
Publicado: (2021) -
Breaking Immunological Tolerance in Systemic Lupus Erythematosus
por: Pieterse, Elmar, et al.
Publicado: (2014) -
The Potential Role of Ferroptosis in Systemic Lupus Erythematosus
por: Chen, Qian, et al.
Publicado: (2022) -
A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus
por: Curtiss, Paul, et al.
Publicado: (2022)